<DOC>
	<DOCNO>NCT00354614</DOCNO>
	<brief_summary>The primary endpoint study AL validation 1 ) achieve sensitivity great 80 % AHI value great equal 15 , 2 ) demonstrate correlation coefficient r=0.75 indicate strong correlation AHI diagnostic PSG AL .</brief_summary>
	<brief_title>Validation ApneaLink Sleep Screener Obstructive Sleep Apnea ( OSA )</brief_title>
	<detailed_description>All subject suspect Sleep Disordered Breathing ( SDB ) schedule diagnostic polysomnography ( PSG ) invite participate study test determine Sleep Disordered Breathing ( SDB ) , use ApneaLink ( AL ) Sleep Screener . Subjects initially test SDB home environment . Following AL home test , subject undergo simultaneous , attend diagnostic polysomnography ( PSG ) sleep study ApneaLink test purpose confirm compare result diagnostic PSG AL device .</detailed_description>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Adult subject ( great 18 year age ) either gender race Suspected sleep disorder breathing Untreated sleep disordered breathing Willingness use AL home within 2 day receipt instruction AL Willingness use AL home undergo PSG within 2 4 week complete home AL test Any subject requiring home oxygen therapy Any subject currently receive positive airway pressure therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
</DOC>